Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.









Project Scope 

This project aims to create a guidance about best data practices for patient foundations and for researchers in the form of decision trees, graphics, short printable materials or videos.


Project Statement 

The purpose of this Working Group is to create awareness and education about best practices for collecting regulatory quality data from the industry perspective, improving data quality, empowering patients and patient groups with knowledge and information, and building bridges between industry, academics and patient communities.


Project Impact 

This project will create greater partnership between industry, researchers and the patient community. It will also help improve data collection, with the goal of the data being useful to the industry.




Lauren White lauren@phuse 
Project LeadsEmail

Sophia Zilber (Alexion, Cure Mito Foundation)

sophia.zilber@alexion.com

Danielle Boyce (Johns Hopkins University)

dboyce3@jhu.edu
Parag Shiralkar (Sumptuous Data Sciences)parag.shiralkar@sumptuous-ds.com
Alex Pearce (PHUSE Project Coordinator

Alexandra@phuse.global


Objectives & Deliverables

Timelines

Decide on a strategy to share all three resources, possibly through PHUSE Education webinars Q2 2023


Status
colourBlue
titleCurrent Status
Q2/3 2022

Published the following resources:

  • What Patient Foundations Should Know When Starting a Patient Registry 
  • Transparency Checklist 

Finalising final resource, Myths & Facts.




Project Members

Organisation

Andrew MulbergNeurogene
Daijiro Wachi Yuimedi
Eva-Maria DiddenJanssen Research & Development
Gregory Pursley BioCryst
Jodi HolmaneClinical
Kamlesh Patel Rang Technologies
Kelly Huang Yuimedi 
Monika Brand Janssen Research & Development
Olivia Montano PROS Foundation
Paul HowardAmicus Therapeutics
Ryosuke IzawaYuimedi
Samantha RobicheauDatavant
Sanath RameshCuresDev
Shabeeb KannattikuniICON
Stephen Mc Cawille Veramed 
Tripti BhaskaranGSK
Valerie Van Baalen Janssen Research & Development